ArticleJournal of hematology & oncology2022

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.

Ming Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.